Vivesto AB
(OTCPK:OASMY)
$
0.05
0 (0%)
Market Cap: 8.97 Mil
Enterprise Value: 4.60 Mil
PE Ratio: 0
PB Ratio: 0.77
GF Score: 40/100 Q2 2021 Oasmia Pharmaceutical AB Earnings Call Transcript
Aug 19, 2021 / 08:00AM GMT
Release Date Price:
$0.92255
Operator
Welcome to the Oasmia Pharmaceutical Audiocast Teleconference Q2 2021. With us today, we have CEO, Francois R. Martelet; and CFO, Fredrik Jarrsten.
(Operator Instructions) I will now hand over to Francois. Please go ahead.
Francois R. Martelet;publ;CEO
Oasmia Pharmaceutical AB
()-
Thank you very much, and good morning, everyone. It's a pleasure to provide you with an update on our Q2 and interim results, together with our CFO, Fredrik Jarrsten.
Fredrik Jarrsten;publ;CFO
Oasmia Pharmaceutical AB
()-
Good morning.
Francois R. Martelet;publ;CEO
Oasmia Pharmaceutical AB
()-
So Slide 2 is forward-looking statement, as I would not ask to read, obviously. Slide 3 is to the speaker slide. So now Slide 4.
So this quarter was essentially a quarter of transition and build, as we continue to a greater level of internal capabilities, continue to make the best decisions
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot